Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001970776 | SCV002267168 | pathogenic | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2024-01-02 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 28 of the WDR19 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in WDR19 are known to be pathogenic (PMID: 22019273, 23559409, 23683095, 26275793, 27241786, 29068549). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with WDR19-related conditions (PMID: 34529350, 36909829). ClinVar contains an entry for this variant (Variation ID: 1473602). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Ophthalmic Genetics Group, |
RCV003324579 | SCV004030351 | pathogenic | Renal dysplasia and retinal aplasia | 2023-07-24 | criteria provided, single submitter | research | Clinical significance based on ACMG v2.0 |